1. Medical discovery gives new insight into lupus treatment
PRC.TODAY - Medical workers from Shanghai Renji Hospital teamed up with experts from the United States and Australia for a study that found that a defect in the expression or function of one protein may be an important risk factor for developing lupus.
This opens up new possibilities for treating autoimmune disease.
The discovery was published in the world's leading journal of experimental medicine.
Systemic lupus erythematosus, or SLE, is a multisystem autoimmune disease with complex causes, poor treatment response, and high mortality.
Research has shown that the disease is closely linked to environment and genetics. For example, SLE has a much higher incidence among identical twins.
Based on the sample database at Renji Hospital, doctors conducted a genetic study of samples from nearly 1,000 patients and their family members. They found that the P2RY8 protein plays an important jamaica telegram number database role in lupus patients. Mutations in the protein play a major role in the onset and progression of SLE.
According to experts, this discovery offers a new target for the treatment of autoimmune diseases and has very positive implications for clinical application.
2. China's first magnetically levitated artificial heart approved for commercial use
China's first domestically produced magnetic levitation artificial heart, developed by CH Biomedical in Suzhou , east China's Jiangsu Province, has been approved for commercial use, indicating that heart failure surgery in China has entered the artificial heart era, the president of a hospital said at a seminar.
Hu Shengshou, president of Shenzhen-based Fuwai Hospital, spoke on Saturday during a seminar on severe heart disease. Hu Shengshou said heart failure is the final stage of heart disease, and as China enters the age of aging, the incidence of heart failure continues to rise.